SlideShare une entreprise Scribd logo
1  sur  29
Missouri-Behavioral Pharmacy Management Program Laine Young-Walker, M.D. Associate Medical Director Department of Mental Health
Missouri-BPM Mailings ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Missouri-BPM Mailings ,[object Object],[object Object],[object Object],[object Object]
Missouri-BPM Mailings ,[object Object],[object Object],[object Object]
Missouri-BPM Mailings ,[object Object],[object Object],[object Object],[object Object]
Missouri-BPM Mailings ,[object Object],[object Object],[object Object]
Missouri-BPM Mailings ,[object Object]
Missouri-BPM Mailings ,[object Object],[object Object],[object Object],[object Object]
Missouri-BPM Mailings ,[object Object],[object Object],[object Object],[object Object],[object Object]
Missouri-BPM Mailings ,[object Object]
 
 
 
Missouri-BPM Mailings ,[object Object],[object Object],[object Object]
Missouri-BPM Mailings ,[object Object],[object Object]
Missouri-BPM Mailings June 2009 to February 2010 Quality Indicator 6/1/09 to 8/31/09 10/1/09 to 12/31/09 12/1/09 to 2/28/10 Adult use of 5 or more Psychotropic Meds for 60 days or more 29 26 34 % Hab Center Adult use of 5 or more Psychotropic Meds for 60 or more days 5.51% 5.22% 6.49% Adult use of 2 or more Antipsychotic Meds for 60 days or more 63 63 63 % Hab Center Adult use of 2 or more Antipsychotic Meds for 60 days or more 11.98% 12.65% 12.02% Adult Use of Benzodiazepines at higher than recommended dose for 60 days or more 19 19 19 % Hab Center Adult use Benzodiazepines at higher than recommended dose for 60 days or more 3.61% 3.82% 3.63% Habilitation Center Adults with MHN Behavioral Medication Claims 526 498 524
Missouri-BPM Mailings June 2009 to February 2010
Missouri-BPM Mailings October 2007 to August 2008 Quality Indicator 6/1/08 to 8/31/08 3/1/08 to 5/31/08 12/1/07 to 2/28/08 10/1/07 to 12/31/07 Adult use of 5 or more Psychotropic Meds for 60 days or more 23 18 10 12 % Hab Center Adult use of 5 or more Psychotropic Meds for 60 or more days 3.91% 2.96% 1.81% 2.38% Adult use of 2 or more Antipsychotic Meds for 60 days or more 66 45 38 43 % Hab Center Adult use of 2 or more Antipsychotic Meds for 60 days or more 11.22% 7.40% 6.87% 8.51% Adult Use of Benzodiazepines at higher than recommended dose for 60 days or more 25 24 24 26 % Hab Center Adult use Benzodiazepines at higher than recommended dose or 60 days or more 4.25 3.95% 4.34% 5.15% Habilitation Center Adults with MHN Behavioral Medication Claims 588 608 553 505
Missouri-BPM Mailings October 2007 to August 2008
Missouri-BPM Mailings Comparison of Initial and Present Data
Missouri-BPM Mailings Benchmark for Most Recent Mailing  December 2009 to February 2010 Hab Center Census Total Scripts Scripts/Resident % Outlier SEMORS 77 549 7.26 36.25% Marshall 197 883 4.48 32.39% Nevada 117 910 7.78 30.22% Higginsville 143 1742 12.18 24.86% DDTC 188 1700 9.04 17.65% Bellefountaine 145 278 1.92 16.55%
 
 
Missouri-BPM Mailings Benchmark for Most Recent Mailing  October 2007 to December 2007 Hab Center Census Total Scripts Scripts/Resident % Outlier SEMORS 75 570 7.60 30.0% Marshall 206 847 4.11 33.7% Nevada 140 1181 8.44 22.1% Higginsville 110 763 6.94 16.5% DDTC 220 900 4.09 6.8% Bellefountaine 161 343 2.13 8.2%
Missouri-BPM Mailings Comparison of 10/07 and 12/09 Benchmark Report
Missouri-BPM Mailings  Comparison of 10/07 and 12/09 Benchmark Report
Missouri-BPM Mailings  Comparison of 10/07 and 12/09 Benchmark Report
Missouri-BPM Mailings ,[object Object],[object Object],[object Object]
Missouri-BPM Mailings ,[object Object],[object Object]

Contenu connexe

Tendances

CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...University of Michigan Injury Center
 
Factors Associated with Reduction in Inpatient Days by VA Home Based Primary ...
Factors Associated with Reduction in Inpatient Days by VA Home Based Primary ...Factors Associated with Reduction in Inpatient Days by VA Home Based Primary ...
Factors Associated with Reduction in Inpatient Days by VA Home Based Primary ...Leonard Davis Institute of Health Economics
 
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...University of Michigan Injury Center
 
LCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLELCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLETony Fanelli
 
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPH
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPHImproving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPH
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPHUniversity of Michigan Injury Center
 
Rodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReadyRodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReadyKate Lee, MPH
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 
Comparative effectiveness analysis and quality of life(2)
Comparative effectiveness analysis and quality of life(2)Comparative effectiveness analysis and quality of life(2)
Comparative effectiveness analysis and quality of life(2)elamar129
 
Comparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of lifeComparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of lifeelamar129
 
Comparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of lifeComparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of lifeelamar129
 
Rx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williamsRx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williamsOPUNITE
 
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartnerRx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartnerOPUNITE
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchOPUNITE
 
Rx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisherRx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisherOPUNITE
 
Rx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwaltRx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwaltOPUNITE
 
Using Quality Measurement and Reporting to Confront Disparities
Using Quality Measurement and Reporting to Confront DisparitiesUsing Quality Measurement and Reporting to Confront Disparities
Using Quality Measurement and Reporting to Confront Disparitiesgueste165460
 

Tendances (19)

CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
 
Factors Associated with Reduction in Inpatient Days by VA Home Based Primary ...
Factors Associated with Reduction in Inpatient Days by VA Home Based Primary ...Factors Associated with Reduction in Inpatient Days by VA Home Based Primary ...
Factors Associated with Reduction in Inpatient Days by VA Home Based Primary ...
 
FMCC 2016 Teaching Health Centers Plenary by Winston Liaw
FMCC 2016 Teaching Health Centers Plenary by Winston LiawFMCC 2016 Teaching Health Centers Plenary by Winston Liaw
FMCC 2016 Teaching Health Centers Plenary by Winston Liaw
 
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...
 
FMCC 2016 Health Is Primary by Robert Phillips
FMCC 2016 Health Is Primary by Robert PhillipsFMCC 2016 Health Is Primary by Robert Phillips
FMCC 2016 Health Is Primary by Robert Phillips
 
LCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLELCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLE
 
Drug Addiction Final pptx
Drug Addiction Final pptxDrug Addiction Final pptx
Drug Addiction Final pptx
 
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPH
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPHImproving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPH
Improving Opioid Prescribing in VA Primary Care by Erin E. Krebs, MD, MPH
 
Rodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReadyRodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReady
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Comparative effectiveness analysis and quality of life(2)
Comparative effectiveness analysis and quality of life(2)Comparative effectiveness analysis and quality of life(2)
Comparative effectiveness analysis and quality of life(2)
 
Comparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of lifeComparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of life
 
Comparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of lifeComparative effectiveness analysis and quality of life
Comparative effectiveness analysis and quality of life
 
Rx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williamsRx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williams
 
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartnerRx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
Rx15 pdmp tues_1115_1_adams-droz-ryan_2baumgartner
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
 
Rx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisherRx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisher
 
Rx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwaltRx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwalt
 
Using Quality Measurement and Reporting to Confront Disparities
Using Quality Measurement and Reporting to Confront DisparitiesUsing Quality Measurement and Reporting to Confront Disparities
Using Quality Measurement and Reporting to Confront Disparities
 

Similaire à Laine statewide dd meeting bpm mailings 4 13

Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderOPUNITE
 
Dr. Mollyann Brodie: "What Soaring Drug Prices Mean for Patients," 9.3.15
Dr. Mollyann Brodie: "What Soaring Drug Prices Mean for Patients," 9.3.15Dr. Mollyann Brodie: "What Soaring Drug Prices Mean for Patients," 9.3.15
Dr. Mollyann Brodie: "What Soaring Drug Prices Mean for Patients," 9.3.15reportingonhealth
 
mHealth Service for HIV Prevention and Care
mHealth Service for HIV Prevention and CaremHealth Service for HIV Prevention and Care
mHealth Service for HIV Prevention and CareYTH
 
Mental Health Medication Use in Washington
Mental Health Medication Use in WashingtonMental Health Medication Use in Washington
Mental Health Medication Use in WashingtonMHTP Webmastere
 
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbellRx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbellOPUNITE
 
Hbp Stategy Hypertension Management Initiative Feb07
Hbp Stategy Hypertension Management Initiative Feb07Hbp Stategy Hypertension Management Initiative Feb07
Hbp Stategy Hypertension Management Initiative Feb07primary
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroOPUNITE
 
Thesis Defense [06102010]
Thesis Defense [06102010]Thesis Defense [06102010]
Thesis Defense [06102010]rpunekar
 
Rx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notesRx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notesOPUNITE
 
Wed gs frieden
Wed gs friedenWed gs frieden
Wed gs friedenOPUNITE
 
Barriers to bup among rural physicians
Barriers to bup among rural physiciansBarriers to bup among rural physicians
Barriers to bup among rural physiciansPaul Coelho, MD
 
Blazing New Trails: Shifting the Focus on Alcohol and Drugs
Blazing New Trails: Shifting the Focus on Alcohol and DrugsBlazing New Trails: Shifting the Focus on Alcohol and Drugs
Blazing New Trails: Shifting the Focus on Alcohol and Drugsnashp
 
Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...M. Christopher Roebuck
 
UTSpeaks: A medicated nation (Part 1: Prof Shalom Benrimoj)
UTSpeaks: A medicated nation (Part 1: Prof Shalom Benrimoj)UTSpeaks: A medicated nation (Part 1: Prof Shalom Benrimoj)
UTSpeaks: A medicated nation (Part 1: Prof Shalom Benrimoj)University of Technology, Sydney
 
smi patient recruitment programs
smi patient recruitment programssmi patient recruitment programs
smi patient recruitment programsnicoleriv
 
Statewide Narcotics Screening Project
Statewide Narcotics Screening ProjectStatewide Narcotics Screening Project
Statewide Narcotics Screening ProjectTrevor Rohm
 

Similaire à Laine statewide dd meeting bpm mailings 4 13 (20)

Ira Klein, Can Value-based Contracting Work for Pharma Companies?
Ira Klein, Can Value-based Contracting Work for Pharma Companies?Ira Klein, Can Value-based Contracting Work for Pharma Companies?
Ira Klein, Can Value-based Contracting Work for Pharma Companies?
 
Twillman preventing rx abuse
Twillman preventing rx abuseTwillman preventing rx abuse
Twillman preventing rx abuse
 
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
 
Dr. Mollyann Brodie: "What Soaring Drug Prices Mean for Patients," 9.3.15
Dr. Mollyann Brodie: "What Soaring Drug Prices Mean for Patients," 9.3.15Dr. Mollyann Brodie: "What Soaring Drug Prices Mean for Patients," 9.3.15
Dr. Mollyann Brodie: "What Soaring Drug Prices Mean for Patients," 9.3.15
 
mHealth Service for HIV Prevention and Care
mHealth Service for HIV Prevention and CaremHealth Service for HIV Prevention and Care
mHealth Service for HIV Prevention and Care
 
Mental Health Medication Use in Washington
Mental Health Medication Use in WashingtonMental Health Medication Use in Washington
Mental Health Medication Use in Washington
 
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbellRx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
 
Hbp Stategy Hypertension Management Initiative Feb07
Hbp Stategy Hypertension Management Initiative Feb07Hbp Stategy Hypertension Management Initiative Feb07
Hbp Stategy Hypertension Management Initiative Feb07
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
 
Thesis Defense [06102010]
Thesis Defense [06102010]Thesis Defense [06102010]
Thesis Defense [06102010]
 
Rx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notesRx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notes
 
Wed gs frieden
Wed gs friedenWed gs frieden
Wed gs frieden
 
Barriers to bup among rural physicians
Barriers to bup among rural physiciansBarriers to bup among rural physicians
Barriers to bup among rural physicians
 
presentation
presentationpresentation
presentation
 
Blazing New Trails: Shifting the Focus on Alcohol and Drugs
Blazing New Trails: Shifting the Focus on Alcohol and DrugsBlazing New Trails: Shifting the Focus on Alcohol and Drugs
Blazing New Trails: Shifting the Focus on Alcohol and Drugs
 
Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...Impact of Antidepressant Medication Adherence on Health Services Utilization ...
Impact of Antidepressant Medication Adherence on Health Services Utilization ...
 
UTSpeaks: A medicated nation (Part 1: Prof Shalom Benrimoj)
UTSpeaks: A medicated nation (Part 1: Prof Shalom Benrimoj)UTSpeaks: A medicated nation (Part 1: Prof Shalom Benrimoj)
UTSpeaks: A medicated nation (Part 1: Prof Shalom Benrimoj)
 
smi patient recruitment programs
smi patient recruitment programssmi patient recruitment programs
smi patient recruitment programs
 
Ethical issues and HTA
Ethical issues and HTAEthical issues and HTA
Ethical issues and HTA
 
Statewide Narcotics Screening Project
Statewide Narcotics Screening ProjectStatewide Narcotics Screening Project
Statewide Narcotics Screening Project
 

Laine statewide dd meeting bpm mailings 4 13

  • 1. Missouri-Behavioral Pharmacy Management Program Laine Young-Walker, M.D. Associate Medical Director Department of Mental Health
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.  
  • 12.  
  • 13.  
  • 14.
  • 15.
  • 16. Missouri-BPM Mailings June 2009 to February 2010 Quality Indicator 6/1/09 to 8/31/09 10/1/09 to 12/31/09 12/1/09 to 2/28/10 Adult use of 5 or more Psychotropic Meds for 60 days or more 29 26 34 % Hab Center Adult use of 5 or more Psychotropic Meds for 60 or more days 5.51% 5.22% 6.49% Adult use of 2 or more Antipsychotic Meds for 60 days or more 63 63 63 % Hab Center Adult use of 2 or more Antipsychotic Meds for 60 days or more 11.98% 12.65% 12.02% Adult Use of Benzodiazepines at higher than recommended dose for 60 days or more 19 19 19 % Hab Center Adult use Benzodiazepines at higher than recommended dose for 60 days or more 3.61% 3.82% 3.63% Habilitation Center Adults with MHN Behavioral Medication Claims 526 498 524
  • 17. Missouri-BPM Mailings June 2009 to February 2010
  • 18. Missouri-BPM Mailings October 2007 to August 2008 Quality Indicator 6/1/08 to 8/31/08 3/1/08 to 5/31/08 12/1/07 to 2/28/08 10/1/07 to 12/31/07 Adult use of 5 or more Psychotropic Meds for 60 days or more 23 18 10 12 % Hab Center Adult use of 5 or more Psychotropic Meds for 60 or more days 3.91% 2.96% 1.81% 2.38% Adult use of 2 or more Antipsychotic Meds for 60 days or more 66 45 38 43 % Hab Center Adult use of 2 or more Antipsychotic Meds for 60 days or more 11.22% 7.40% 6.87% 8.51% Adult Use of Benzodiazepines at higher than recommended dose for 60 days or more 25 24 24 26 % Hab Center Adult use Benzodiazepines at higher than recommended dose or 60 days or more 4.25 3.95% 4.34% 5.15% Habilitation Center Adults with MHN Behavioral Medication Claims 588 608 553 505
  • 19. Missouri-BPM Mailings October 2007 to August 2008
  • 20. Missouri-BPM Mailings Comparison of Initial and Present Data
  • 21. Missouri-BPM Mailings Benchmark for Most Recent Mailing December 2009 to February 2010 Hab Center Census Total Scripts Scripts/Resident % Outlier SEMORS 77 549 7.26 36.25% Marshall 197 883 4.48 32.39% Nevada 117 910 7.78 30.22% Higginsville 143 1742 12.18 24.86% DDTC 188 1700 9.04 17.65% Bellefountaine 145 278 1.92 16.55%
  • 22.  
  • 23.  
  • 24. Missouri-BPM Mailings Benchmark for Most Recent Mailing October 2007 to December 2007 Hab Center Census Total Scripts Scripts/Resident % Outlier SEMORS 75 570 7.60 30.0% Marshall 206 847 4.11 33.7% Nevada 140 1181 8.44 22.1% Higginsville 110 763 6.94 16.5% DDTC 220 900 4.09 6.8% Bellefountaine 161 343 2.13 8.2%
  • 25. Missouri-BPM Mailings Comparison of 10/07 and 12/09 Benchmark Report
  • 26. Missouri-BPM Mailings Comparison of 10/07 and 12/09 Benchmark Report
  • 27. Missouri-BPM Mailings Comparison of 10/07 and 12/09 Benchmark Report
  • 28.
  • 29.